hemodialysis. Extracorporeal dialysis
Conditions
Interventions
Intervention 1: Intervention group: Isowhey oral nutritional supplement daily - a cup (24 grams) for two months. Intervention 2: Control group: No action.
Prevention
Intervention group: Isowhey oral nutritional supplement daily - a cup (24 grams) for two months.
Control group: No action
Sponsors
Vice Chancellor for research of Nursing Faculty, Baqiyatallah University of Medical Sciences
Exercise Physiology Research Center, Baqiyatallah University of Medical Sciences,
Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences,
Nutrition Research Center, Baqiyatallah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Written informed consent to participate in research Albumin less than 4 g per deciliter before the study. At least 6 months have been treated with hemodialysis. Older than 18 and younger than 75 years Hemodialysis: two or more times per week 35kg/m2 >BMI> 18.5 kg / m2 Absence of acute infection Absence of heart failure or severe respiratory Absence of chronic inflammatory disease with unknown sources Not using immunosuppressive drugs Absence of parenteral nutrition Absence of recent surgery or during follow up over the past three months. Absence of chronic liver disease Absence of nephritic syndrome Absence of cancer, dementia, Neurological Disease Absence of hepatitis B, hepatitis C, HIV, infection in the last 4 weeks Exclusion criteria: Allergic complications caused by oral nutritional supplements Confirmation of any problems that the inclusion criteria listed during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dialysis adequacy. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: DaugirddasII.;Dialysis adequacy. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: URR=BUN1-BUN2/BUN1. | — |
Secondary
| Measure | Time frame |
|---|---|
| Albomin. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Total Iron Binding Capacity. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Blood Urea Nitrogen. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Calcium. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Phosphorus. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Creatinine. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Sodium. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests.;Potassium. Timepoint: Baseline, one month after the start of intervention, two months after the intervention. Method of measurement: Blood tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEffat Afaghi
Nursing Faculty, Baqiyatallah University of Medical Sciences
Outcome results
None listed